A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration

Purpose. To report a case of atrioventricular block (AVB) which might be associated with the right coronary artery lesion and the novel oral antithrombotic drug ticagrelor mediated by the increasing adenosine plasma concentration (APC). Case Report. A 65-year-old man was given loading dose of ticagr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoye Li, Ying Xue, Hongyi Wu
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Vascular Medicine
Online Access:http://dx.doi.org/10.1155/2018/9385017
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564291844177920
author Xiaoye Li
Ying Xue
Hongyi Wu
author_facet Xiaoye Li
Ying Xue
Hongyi Wu
author_sort Xiaoye Li
collection DOAJ
description Purpose. To report a case of atrioventricular block (AVB) which might be associated with the right coronary artery lesion and the novel oral antithrombotic drug ticagrelor mediated by the increasing adenosine plasma concentration (APC). Case Report. A 65-year-old man was given loading dose of ticagrelor (180 mg) before coronary angiography with total thrombotic occlusion of right coronary artery and one stent was implanted. On second day after successful percutaneous coronary intervention, ECG monitoring showed second-degree (Mobitz type I) AVB with prolonged PR interval (299 ms). Hypothesis was drawn that elevated APC levels caused by ticagrelor would be the reason for AVB after excluding combination drugs or underlying disease. APC might be an indicator of this side effect caused by the P2Y12 receptor inhibitors. On fourth day after shifting to clopidogrel, the ECG showed normal sinus rhythm and PR interval depressed to 190 ms and APC dropped from 1.62 umol/L to 0.92 umol/L. The bradycardia and AVB did not occur in the three-month follow-up. Conclusion. It was important to take the ticagrelor induced bradycardia into account particularly with the myocardial infarction of right coronary artery, treated with atrioventricular block drugs after initiating ticagrelor. Also, we should shift ticagrelor to clopidogrel if AVB occurred.
format Article
id doaj-art-bea3f35a82e84ee0aa32d1969aed8525
institution Kabale University
issn 2090-6986
2090-6994
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Vascular Medicine
spelling doaj-art-bea3f35a82e84ee0aa32d1969aed85252025-02-03T01:11:20ZengWileyCase Reports in Vascular Medicine2090-69862090-69942018-01-01201810.1155/2018/93850179385017A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma ConcentrationXiaoye Li0Ying Xue1Hongyi Wu2Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaPurpose. To report a case of atrioventricular block (AVB) which might be associated with the right coronary artery lesion and the novel oral antithrombotic drug ticagrelor mediated by the increasing adenosine plasma concentration (APC). Case Report. A 65-year-old man was given loading dose of ticagrelor (180 mg) before coronary angiography with total thrombotic occlusion of right coronary artery and one stent was implanted. On second day after successful percutaneous coronary intervention, ECG monitoring showed second-degree (Mobitz type I) AVB with prolonged PR interval (299 ms). Hypothesis was drawn that elevated APC levels caused by ticagrelor would be the reason for AVB after excluding combination drugs or underlying disease. APC might be an indicator of this side effect caused by the P2Y12 receptor inhibitors. On fourth day after shifting to clopidogrel, the ECG showed normal sinus rhythm and PR interval depressed to 190 ms and APC dropped from 1.62 umol/L to 0.92 umol/L. The bradycardia and AVB did not occur in the three-month follow-up. Conclusion. It was important to take the ticagrelor induced bradycardia into account particularly with the myocardial infarction of right coronary artery, treated with atrioventricular block drugs after initiating ticagrelor. Also, we should shift ticagrelor to clopidogrel if AVB occurred.http://dx.doi.org/10.1155/2018/9385017
spellingShingle Xiaoye Li
Ying Xue
Hongyi Wu
A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
Case Reports in Vascular Medicine
title A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
title_full A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
title_fullStr A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
title_full_unstemmed A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
title_short A Case of Atrioventricular Block Potentially Associated with Right Coronary Artery Lesion and Ticagrelor Therapy Mediated by the Increasing Adenosine Plasma Concentration
title_sort case of atrioventricular block potentially associated with right coronary artery lesion and ticagrelor therapy mediated by the increasing adenosine plasma concentration
url http://dx.doi.org/10.1155/2018/9385017
work_keys_str_mv AT xiaoyeli acaseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration
AT yingxue acaseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration
AT hongyiwu acaseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration
AT xiaoyeli caseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration
AT yingxue caseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration
AT hongyiwu caseofatrioventricularblockpotentiallyassociatedwithrightcoronaryarterylesionandticagrelortherapymediatedbytheincreasingadenosineplasmaconcentration